Burstein et al., 1980 - Google Patents
Megakaryocytopoiesis in culture: Modulation by cholinergic mechanismsBurstein et al., 1980
- Document ID
- 8075060009477659918
- Author
- Burstein S
- Adamson J
- Harker L
- Publication year
- Publication venue
- Journal of Cellular Physiology
External Links
Snippet
Abstract Treatment of murine bone marrow cultures with the cholinergic agonist carbamylcholine enhanced megakaryocytic colony growth by as much as 65%. In contrast, adrenergic agonists had no such effect. Addition to cultures of dibutyryl cyclic GMP (db …
- 230000001713 cholinergic 0 title abstract description 26
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/746—Erythropoetin
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Burstein et al. | Megakaryocytopoiesis in culture: Modulation by cholinergic mechanisms | |
| Brown et al. | Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation. | |
| Mazur et al. | Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans | |
| Goodwin et al. | Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro: changes with mitogen dose and preincubation | |
| Metz et al. | Deranged DNA synthesis by bone marrow from vitamin B12‐deficient humans | |
| Koren et al. | Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins. | |
| Mager et al. | Early transport changes during erythroid differentiation of Friend leukemic cells | |
| Suda et al. | Permissive role of interleukin 3 (IL‐3) in proliferation and differentiation of multipotential hemopoietic progenitors in culture | |
| Tupper et al. | Potassium transport and content during G1 and S phase following serum stimulation of 3T3 cells | |
| Vairo et al. | Inhibition of the signaling pathways for macrophage proliferation by cyclic AMP. Lack of effect on early responses to colony stimulating factor-1. | |
| Wagemaker | Cellular and soluble factors influencing the differentiation of primitive erythroid progenitor cells (BFU-E) in vitro | |
| Campbell et al. | Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis. | |
| Mazia et al. | The nucleus-dependence of P32 uptake by the cell | |
| Bhuyan et al. | Cell cycle phase specificity and biochemical effects of ellipticine on mammalian cells | |
| Bottomley et al. | Effect of cyclic adenosine-3′, 5′-monophosphate on bone marrow Δ-aminolevulinic acid synthetase and erythrocyte iron uptake | |
| Willems | Cell renewal in the gastric mucosa | |
| Wharton et al. | Increases in cyclic AMP potentiate competence formation in BALB/c‐3T3 cells | |
| O'Keefe et al. | Persistence of exogenous, inserted ganglioside GM1 on the cell surface of cultured cells | |
| Preisler et al. | Comparison of tritiated thymidine labeling and suicide indices in acute nonlymphocytic leukemia | |
| Harris et al. | Increased cytolytic T lymphocyte activity induced by 2-mercaptoethanol in mixed leukocyte cultures: kinetics and possible mechanisms of action | |
| Brown et al. | Studies of the influence of cyclic nucleotides on in vitro haemoglobin synthesis | |
| McDonald | The regulation of megakaryocyte and platelet production | |
| Thomas et al. | Studies on the biochemical defect of pernicious anemia. I. In vitro observations on oxygen consumption, heme synthesis and deoxyribonucleic acid synthesis by pernicious anemia bone marrow | |
| Wagemaker et al. | Some characteristics of in vitro erythroid colony and burst-forming units | |
| Miura et al. | Increases in circulating megakaryocyte growth-promoting activity in the plasma of rats following whole body irradiation |